Clinical trial
Effects of Nicorandil on Cardiovascular Events in Patients With Coronary Artery Disease Receiving Hemodialysis
NCT01475123 is registered in ClinicalTrials.gov with Kumamoto University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Nicorandil on Cardiovascular Events in Patients With Coronary Artery Disease Receiving Hemodialysis
- Lead sponsor
- Kumamoto University
- Phase
- Phase 4
- Overall status
- Active, not recruiting
- Start date
- June 30, 2008
- Completion date
- August 31, 2027
- Enrollment
- 268 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coronary artery disease, end stage renal disease